Pharmaceuticals Co. plans to buy back up to 100 million RMB worth of H shares.

Yao Jie Ankang announcement, the company's board of directors announced that, according to the general authorization to repurchase H shares approved by the shareholders' meeting, the company intends to repurchase the company's H shares on the open market from time to time, with a maximum total amount of RMB 100 million or its equivalent in Hong Kong dollars. The repurchase period shall commence from the date of approval by the shareholders' meeting and shall expire at the end of the next annual shareholders' meeting or when the deadline for convening the next annual shareholders' meeting as required by relevant laws expires, or on the date of revocation or amendment of the special resolution by the shareholders. Repurchase funds shall be disbursed in accordance with applicable laws and regulations.